Paul Thomas

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Branchburg, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Marc Began, as attorney-in-fact for Paul Thomas
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul Thomas

Form 4 holding Director

SURGALIGN HOLDINGS, INC.

Security class
Common Stock
Shares / value
28,610
Estimated value
$5,236
Report date
15 Aug 2022
Price
$0.1830
Ownership
Direct
Form 4 holding Director

Axogen, Inc.

Security class
Restricted Stock Units
Shares / value
5,579
Estimated value
$0
Report date
24 Jun 2026
Price
$7.68
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TELA Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
17,335
Estimated value
Report date
09 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ABIOMED INC

Security class
Common Stock, $.01 par value
Shares / value
0
Estimated value
Report date
22 Dec 2022
Price
$373.99
Ownership
Direct

Insider Reports Filed by Paul Thomas

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .